YB

Yolanda Bobeldijk

Blue Water Energy hits $861m hard-cap

The first time fund, which will invest in mid-market oil and gas businesses predominantly in Europe, reached its hard-cap after spending less than a year on the fundraising trail.

2 min read · 20 September 2013

NBK Capital exits Turkish hospital chain

The divestment of the ophthalmology hospital chain comes as the firm is trying to raise $300m for its NBK Capital Equity Partners Fund II.

1 min read · 20 September 2013

Graphite books 2.3x on Scottish exit

The UK-focused firm has sold Dominion Gas, an Aberdeen-based oilfield services business, to New York-listed Praxair, for approximately £100m.

2 min read · 20 September 2013

EVCA: PE-backed companies boost European innovation

While private equity-backed companies account for less than 6% of total private sector employment in Europe, they comprise 12% of all industry innovation, a study commissioned by EVCA has found.

2 min read · 20 September 2013

Clearlake inks second deal this week

The US-based firm has taken private fashion retailer Bluefly, just days after it agreed to carve out an oil and gas-related service business from Archer Limited.

2 min read · 20 September 2013

EIF teams up with IP Group for £30m fund

The EIF has joined forces with Top Technology Ventures, the venture capital fund management subsidiary of IP Group, to invest in UK-based spin-out companies from IP Group’s university partnerships.

2 min read · 20 September 2013

Clearlake buys oil services business for $244m

The US special situations firm will make the investment from its Fund III, which blew past its hard-cap earlier this year to close on $785m.

2 min read · 20 September 2013

Sovereign books 5.3x on education provider

It is understood Sovereign attracted interest from The Carlyle Group, Investcorp and Providence Equity Partners, but sold WCL to Nord Anglia Education for £153m.

2 min read · 20 September 2013

Quilvest closes latest fund of funds on $150m

The Luxembourg-listed firm also is in the market with another fund of funds with a $400m target, for which it held a first close on $80m in January.

3 min read · 20 September 2013

3i maintains exit momentum with 2.3x pharma return

The London-listed firm has recorded its eighth exit this year with the secondary sale of Xellia Pharmaceuticals.

2 min read · 20 September 2013

Showing 661 to 670 of 874 results
1…6668…88